I nvestors are struggling with a contradiction at the heart of the market as stocks move into their toughest months of the ...

The S&P 500 risks entering bubble territory once it passes a key threshold, according to strategists at SocGen, and Fed rate ...

Palantir stock surges in pre-market after crushing earnings estimates, boosting Nasdaq 100 and tech stock forecasts across US ...

North Chicago, Illinois-based AbbVie Inc. (ABBV) is a research-based biopharmaceutical company. Valued at a market cap of $348.3 billion, it researches, develops, manufactures, and markets innovative ...

Earnings are in the midst of a "rolling recovery" that'll boost the S&P 500. AI, fiscal policy, and rate cuts will help the ...

Shares of Castle Biosciences soared a day after the company reported an unexpected profit and raised its full-year outlook. The stock was up 35% to $20.64 on Tuesday, which would be its largest rise ...

Shares of TransDigm Group declined after the company cut its full-year revenue outlook on weaker-than-expected sales in the original-equipment-manufacturer market. The stock fell 14% to $1386.42, on ...

Palantir reported more than 50% growth in earnings from U.S. government contracts last quarter, boosted by the White House's push for cost-cutting and adoption of artificial-intelligence technology.

With Wall Street's surge to record highs, the U.S. stock market looks nearly as expensive as ever, and investors are debating whether the lofty valuations are a bearish signal or justified by the ...

Due to Philip Morris’s strong performance relative to the broader market over the past year, Wall Street analysts maintain a strongly optimistic outlook on the stock’s prospects.